
---
title: '呼吸道合胞病毒疫苗和单抗最新研究进展（１）'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://picsum.photos/400/300?random=4300'
author: 科学网
comments: false
date: Fri, 12 Aug 2022 09:44:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4300'
---

<div>   
<p style="line-height: 200%"><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 35px">呼吸道合胞病毒预</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 35px">防制剂曙光在前:</span></strong><a name="OLE_LINK1" href="http://blog.sciencenet.cn/undefined"></a><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 35px">　</span></strong><br></p><p style="line-height: 200%"><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 35px">疫苗和单</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 35px">克隆</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 35px">抗</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 35px"><span style="font-family:Shaker2Lancet-Bold">体</span><span style="font-family:Shaker2Lancet-Bold">百舸争流</span></span></strong></p><p style="margin-left: 0;text-indent: 59px;line-height: 200%"><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">前言：</span></span></strong></p><p style="margin-left: 0;text-indent: 48px;line-height: 200%"><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">新冠病毒大流行的将近３年，也是世界疫苗行业突飞猛进、疫苗研发技术日新月异、硕果累累的３年。疫苗制备的多种技术途径都得到深度开发，若干种新兴的技术途径如</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF">mRNA</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疫苗获得了空前的成功，在世界各地大行其道，在多种传染病以及癌症和其他慢性病的防治领域都在不断开花结果。</span></span></strong></p><p style="line-height: 3em;"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF">　　</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">呼吸道合胞病毒</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;font-size: 24px">Respiratory syncytial virus</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">，</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">）</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">是一种历史悠久、危害极大的传染病，其</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疫苗的研发已经有</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">四</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">十年</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的历史</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">，</span> <span style="font-family:Microsoft YaHei UI">但</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">最初开发的疫苗反而会引发</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疫苗相关性呼吸道疾病（</span>VAERD，Vaccine-associated enhanced respiratory diseases</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">）</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">，即未接触过</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的儿童在接种了疫苗后，如果再接触到该病毒反而会发生更严重的</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疾病。诸如此类的问题导致针对</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的疫苗一直未能</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">上市。</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">乘新冠病毒疫苗大跃进的东风，已赚得盆<strong style="white-space: normal;"><span style="font-family: "Microsoft YaHei UI"; color: #069A2E; letter-spacing: 0px; font-size: 24px; background: #FFFFFF;">满</span></strong>钵满的疫苗巨头如</span></span></strong><a href="https://zh.wikipedia.org/wiki/%E8%BE%89%E7%91%9E" title="辉瑞" target="_blank"><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">辉瑞</span></span></span></strong></a><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">（</span>Pfizer)</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">、</span></span></strong><a href="https://zh.wikipedia.org/wiki/%E8%8E%AB%E5%BE%B7%E7%BA%B3" title="莫德纳" target="_blank"><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">莫德纳</span></span></span></strong></a><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">（</span>Moderna</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">）</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">和</span></span></strong><a href="https://zh.wikipedia.org/wiki/%E8%91%9B%E5%85%B0%E7%B4%A0%E5%8F%B2%E5%85%8B" title="葛兰素史克" target="_blank"><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">葛兰素史克</span></span></span></strong></a><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF">(</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF">GSK)</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">等目前都在</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的疫苗开发上快马加鞭，有望在较短时间内取得重大突破。</span></span></strong></p><p style="margin-left: 0;text-indent: 48px;line-height: 200%"><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疫苗和单克隆抗体研究领域来自世界各地的顶级研究人员（约５０人）近期联名在国际著名专业杂志《</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 24px;background: #FFFFFF">Lancet</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"> Infect Dis</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">》上发表</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">综述论文，介绍相关最新研究进展（见</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">参考文献</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">），本博客将分数次介绍此综述的主要内容。</span></span></strong></p><p style="line-height: 200%"><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 29px">　　目录：</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px">摘要</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">一.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px">前言</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">二.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px">方法</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">三.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">教训（</span><span style="font-family:Shaker2Lancet-Bold">Lessons learned） </span></span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">四.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">活的减毒疫苗（</span><span style="font-family:Shaker2Lancet-Bold">live</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px">attenuated vaccines</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">，</span><span style="font-family:Shaker2Lancet-Bold">LAVs ）</span></span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">五.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">嵌合疫苗（</span><span style="font-family:Shaker2Lancet-Bold">Chimeric ）</span></span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">六.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">亚单位疫苗（</span><span style="font-family:Shaker2Lancet-Bold">Subunit）</span></span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">七.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">基于颗粒的疫苗（</span><span style="font-family:Shaker2Lancet-Bold">Particle-based ）</span></span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">八.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">核酸疫苗（</span><span style="font-family:Shaker2Lancet-Bold">Nucleic acid）</span></span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">九.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">重组载体疫苗（</span><span style="font-family:Shaker2Lancet-Bold">Recombinant vectors）</span></span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">十.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">单克隆抗体（</span><span style="font-family:Shaker2Lancet-Bold">MAbs）</span></span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family:Shaker2Lancet-Bold;color:#231F20;font-weight:bold;font-size:21px">十一.　</span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px">讨论</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 21px"> </span></strong></p><p style="line-height: 200%"><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 29px">摘要</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">呼吸道合胞</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">病毒</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">RSV</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">）</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">是婴儿</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">死亡的第二大常见原因，也是</span>60岁</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">以上</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">老年人发病和死亡的主要原因</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">之一</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">。研制</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">RSV</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">疫苗或免疫预防</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">制剂</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">的努力仍然高度活跃。</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">有</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">33种</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">RSV</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">预防候选</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">产品</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">正在临床开发中，</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">采</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">用</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">了</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">6种</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">不同的</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">疫苗制备</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">方法</span>:</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">重组载体疫苗、亚单位疫苗、颗粒疫苗、减毒活疫苗、嵌合疫苗和核酸疫苗</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">;</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">另外还有若干种</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">单克隆抗体</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">。</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">其中有</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">9</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">种</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">候选药物正在进行</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">三期临床试验</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">。</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">由于已</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">了解</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">强力</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">中和抗体</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">所针对的</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">抗原</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">表位</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">epitopes</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">）</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">，</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">导致从</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">单纯依赖于</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">经验转向合理和基于结构的疫苗和单克隆抗体设计。</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">适</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">用于所有婴儿的半衰期延长</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">的</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">单克隆抗体</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">在高收入国家可能</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">在</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">2022年8月后的</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">1年内</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">获得监管机构批准。正在为</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">年龄大于６个月的较</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">大婴儿研制</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">RSV</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">减毒活疫苗</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">。</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">为</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">保护婴儿</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">而</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">用于孕妇的</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">亚单位疫苗</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">的</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">试验处于后期阶段，</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">正在采用</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">载体、亚单位和核酸</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro-Bold">途径</span></span></span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">开发用于老年人的</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">疫苗</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">。下一步</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">迫切需要采取的步骤</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">包括确保</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">在</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">全球</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">范围使</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">RSV</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">疫苗</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">容易</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">获得</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">并</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">负担得起。</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">本</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">综述</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">概</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">述了</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">正在进行</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">临床开发</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">的</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">RSV</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">疫苗和单克隆抗体，</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">重点是</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">不同的</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">目标人</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">群、抗原和</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">临床</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">试验</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">的</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">结果。</span></strong><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px"> </span></strong></p><p style="line-height: 200%"><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 29px">关键信息</span></strong><span style="font-family: 'Microsoft YaHei';line-height: 200%;color: #2A2B2E;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">（</span></span><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #006F3C;font-size: 21px">Key messages </span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #006F3C;font-size: 21px">）</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">•对中和</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">作用</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">敏感</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">的</span><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">RSV</span></strong><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">表位</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">已有更深入</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">的了解</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">，因此</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">使疫苗和单克隆抗体</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">的</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">设计从</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">基于</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">经验转向基于</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">病毒</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">结构</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">•到</span><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Regular;line-height: 200%;color: #231F20;font-size: 21px">2023年</span></span></strong><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">，可用于所有婴儿预防的半衰期延长的</span><strong><span style="font-family: ScalaLancetPro-Bold;line-height: 200%;color: #231F20;font-size: 21px">RSV</span></strong><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">单克隆抗体将有望进入市场，并可能随后批准一种</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">能</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">保护所有婴儿的</span><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Regular;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Regular">供</span></span></span><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Regular;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Regular">孕产妇</span></span></span><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Regular;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:Shaker2Lancet-Regular">接种</span></span></span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">的</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">疫苗</span><span style=";font-family:Shaker2Lancet-Regular;line-height:200%;color:#231F20;font-size:21px">。</span></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family:Calibri">•</span><span style="font-family:SimSun">对于儿童死亡率负担最高的资源贫</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">乏</span><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family:SimSun">地区，</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">在可以预见的未来还</span><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family:SimSun">没有</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">可用的</span><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family:SimSun">疫苗或单克隆抗体</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">。</span></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family:Calibri">•</span><span style="font-family:SimSun">针对</span><span style="font-family:Calibri">60</span><span style="font-family:SimSun">岁以上老年人的亚单位疫苗、载体疫苗和核酸疫苗</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">正</span><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family:SimSun">处于</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">临床</span><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family:SimSun">试验</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">的后期</span><span style=";font-family:Calibri;line-height:200%;font-size:21px"><span style="font-family:SimSun">阶段</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">。</span></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">（未完待续）</span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 24px">参考文献：</span></strong></p><p style="line-height: 200%;"><em><span style="font-family: Shaker2Lancet-Italic;line-height: 200%;color: #006F3C;font-size: 20px">Natalie I Mazur,</span></em><em>　</em><em><span style="font-family: Shaker2Lancet-Italic;line-height: 200%;color: #006F3C;font-size: 20px">et al., </span></em><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 20px">Respiratory syncytial virus prevention within reach: </span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 20px">the vacc</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 20px">ine and monoclonal antibody landscape, </span></strong><strong><em><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #FF0000;font-size: 20px">Lancet Infect Dis</span></em></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 20px">， </span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 20px">Published online August 8, 2022</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 20px">， </span></strong><span style="line-height: 200%;color: #505050;letter-spacing: 0;font-size: 20px;background: #FFFFFF">DOI:</span><span style="line-height: 200%;color: #505050;letter-spacing: 0;font-size: 20px;background: #FFFFFF"> </span><a href="https://doi.org/10.1016/S1473-3099(22)00291-2" target="_blank"><span style="line-height: 200%;color: #800080;letter-spacing: 0;font-size: 20px;background: #FFFFFF">https://doi.org/10.1016/S1473-3099(22)00291-2</span></a><span style="font-family: SimSun;line-height: 200%;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:SimSun">，</span></span></p><p style="line-height: 200%;"><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext" target="_blank"><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;font-size: 20px">https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext</span></span></strong></a><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #231F20;font-size: 20px">.</span></strong></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-347754-1350903.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-347754-1350903.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1350607.html" target="_black">迎接2022年世界狂犬病日</a><br>下一篇：<a href="http://blog.sciencenet.cn/blog-347754-1350986.html" target="_black">呼吸道合胞病毒疫苗和单抗最新研究进展（2）</a>                    <!--大赛结束-->
                                        
  
</div>
            